An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...
TMUBMUSD03M | A complete U.S. 3 Month Treasury Bill bond overview by MarketWatch. View the latest bond prices, bond market news and bond rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results